Area of research
Cancer Research · Pharmacology
Research interest
Research interests include Cancer, Lipids, and Metabolism, Antibiotics Pharmacokinetics and Efficacy, Adolescent Sexual and Reproductive Health, and Prostate Cancer Treatment and Research.
Design, synthesis, and evaluation of a carboxylesterase detection probe with therapeutic effects
Comparative analysis of the effect of nano‑copper and Cu2O treatment on Cryptocaryon irritans tomonts in large yellow croaker (Larimichthys crocea) farming
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes
A quantitative systems pharmacology approach to predict the safe‐equivalent dose of doxorubicin in patients with cardiovascular comorbidity
Toward Greater Insights on Applications of Modeling and Simulation in Pregnancy
Short-term acceptability of the Woman’s Condom and influencing factors among internal migrants in China
Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial
Urinary Antibiotics of Pregnant Women in Eastern China and Cumulative Health Risk Assessment
Metabolite characterization of a novel sedative drug, remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry
Label-free single-cell protein quantification using a drop-based mix-and-read system
Rapid and sensitive screening and selective quantification of antibiotics in human urine by two-dimensional ultraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry
Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical Features, Treatment Modalities, and Prognosis
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer